FDA.reportPublic FDA data

Conjupri

Product NDC
66992-425
11-digit product format
669920425
Labeler code
66992
Product ID
66992-425_de229406-ef83-70e5-e053-2995a90ae939
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
levamlodipine
Dosage form
TABLET
Route
ORAL
Labeler
WraSer LLC
Application
NDA212895
Marketing category
NDA
Marketing start
2021-08-15
Marketing end
0000-00-00
Substance
LEVAMLODIPINE MALEATE
Active strength
3 mg/1
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
99ce1bff-cadd-48bc-9910-990f58aed76bProduct name120200604

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
66992-425-302024-01-30C16284748780-11030e365-671b-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
66992-425-30Conjupri30 in 1 BOTTLETABLET302

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
66992-425-30EA - Each66992-4258d861c0a-56d3-477f-b3eb-dffcad7492b812022-05-04

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
66992-425CONJUPRI (LEVAMLODIPINE) TABLET [WRASER LLC]2Legacy NDC, 1 package rows20220504_f389d4dd-82fd-43a3-8fc4-d8d7a3706fd4.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2377369CONJUPRI 2.5 MG Oral TabletPSNf389d4dd-82fd-43a3-8fc4-d8d7a3706fd42
2377373CONJUPRI 5 MG Oral TabletPSNf389d4dd-82fd-43a3-8fc4-d8d7a3706fd42
2377367levamlodipine 2.5 MG Oral TabletPSNf389d4dd-82fd-43a3-8fc4-d8d7a3706fd42
2377371levamlodipine 5 MG Oral TabletPSNf389d4dd-82fd-43a3-8fc4-d8d7a3706fd42
2377369levamlodipine 2.5 MG Oral Tablet [Conjupri]SBDf389d4dd-82fd-43a3-8fc4-d8d7a3706fd42
2377373levamlodipine 5 MG Oral Tablet [Conjupri]SBDf389d4dd-82fd-43a3-8fc4-d8d7a3706fd42
2377367levamlodipine 2.5 MG Oral TabletSCDf389d4dd-82fd-43a3-8fc4-d8d7a3706fd42
2377371levamlodipine 5 MG Oral TabletSCDf389d4dd-82fd-43a3-8fc4-d8d7a3706fd42
2377369Conjupri 2.5 MG (equivalent to levamlodipine maleate 3.2 MG) Oral TabletSYf389d4dd-82fd-43a3-8fc4-d8d7a3706fd42
2377369Conjupri 2.5 MG Oral TabletSYf389d4dd-82fd-43a3-8fc4-d8d7a3706fd42
2377373Conjupri 5 MG (equivalent to levamlodipine maleate 6.4 MG) Oral TabletSYf389d4dd-82fd-43a3-8fc4-d8d7a3706fd42
2377373Conjupri 5 MG Oral TabletSYf389d4dd-82fd-43a3-8fc4-d8d7a3706fd42
2377367levamlodipine 2.5 MG (equivalent to levamlodipine maleate 3.2 MG) Oral TabletSYf389d4dd-82fd-43a3-8fc4-d8d7a3706fd42
2377371levamlodipine 5 MG (equivalent to levamlodipine maleate 6.4 MG) Oral TabletSYf389d4dd-82fd-43a3-8fc4-d8d7a3706fd42

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
66992-425-306699204253030 TABLET in 1 BOTTLE (66992-425-30) 30 tablet2021-08-150000-00-00NoNoCurrent